Abstract
BackgroundTreatment with a daily fixed dose combination of ledipasvir/sofosbuvir (LDV/SOF) in tablet form, with and without ribavirin (RBV), has exhibited promising results for the treatment of patients with hepatitis C...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have